132 related articles for article (PubMed ID: 25544168)
1. [Suppression of hepatocellular carcinoma invasion and metastasis by Rho-kinase inhibitor Fasudil through inhibition of BTBD7-ROCK2 signaling pathway].
Hu K; Wang Z; Tao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Dec; 39(12):1221-7. PubMed ID: 25544168
[TBL] [Abstract][Full Text] [Related]
2. [Trametenolic acid inhibits migration and invasion of hepatocellular carcinoma HepG2.2.15 cells via RhoC/ROCK1 pathway].
Wan YL; Wang JZ; Yuan Y; Ye WY; Li HL; Zhang XL; Zhang HQ; Li LE
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):185-196. PubMed ID: 38403351
[TBL] [Abstract][Full Text] [Related]
3. Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation.
Huang D; Du X; Yuan R; Chen L; Liu T; Wen C; Huang M; Li M; Hao L; Shao J
Biochem Biophys Res Commun; 2014 Oct; 453(1):49-56. PubMed ID: 25251472
[TBL] [Abstract][Full Text] [Related]
4. BTB/POZ domain-containing protein 7: epithelial-mesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma.
Tao YM; Huang JL; Zeng S; Zhang S; Fan XG; Wang ZM; Yang HX; Yuan XH; Wang P; Wu F; Luo J; Zeng DY; Shen H
Hepatology; 2013 Jun; 57(6):2326-37. PubMed ID: 23325674
[TBL] [Abstract][Full Text] [Related]
5. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer.
Yang X; Di J; Zhang Y; Zhang S; Lu J; Liu J; Shi W
Biomed Pharmacother; 2012 Apr; 66(3):221-7. PubMed ID: 22425182
[TBL] [Abstract][Full Text] [Related]
6. Effect of fasudil on growth, adhesion, invasion, and migration of 95D lung carcinoma cells in vitro.
Yang X; Zhang Y; Wang S; Shi W
Can J Physiol Pharmacol; 2010 Sep; 88(9):874-9. PubMed ID: 20921973
[TBL] [Abstract][Full Text] [Related]
7. The Rho kinase inhibitor fasudil inhibits the migratory behaviour of 95-D lung carcinoma cells.
Yang X; Liu Y; Zong Z; Tian D
Biomed Pharmacother; 2010 Jan; 64(1):58-62. PubMed ID: 19879105
[TBL] [Abstract][Full Text] [Related]
8. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
Deng L; Li G; Li R; Liu Q; He Q; Zhang J
Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Ras Homolog C/Rho-Associated Coiled-Protein Kinase (Rho/ROCK) Signaling Pathways on Proliferation and Apoptosis of Human Myeloma Cells.
Feng X; Zhang L; Nie S; Zhuang L; Wang W; Huang J; Yan X; Meng F
Med Sci Monit; 2019 Oct; 25():7605-7616. PubMed ID: 31599230
[TBL] [Abstract][Full Text] [Related]
10. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.
Ying H; Biroc SL; Li WW; Alicke B; Xuan JA; Pagila R; Ohashi Y; Okada T; Kamata Y; Dinter H
Mol Cancer Ther; 2006 Sep; 5(9):2158-64. PubMed ID: 16985048
[TBL] [Abstract][Full Text] [Related]
11. Elevated phosphatase of regenerating liver 3 (PRL-3) promotes cytoskeleton reorganization, cell migration and invasion in endometrial stromal cells from endometrioma.
Zhan H; Ma J; Ruan F; Bedaiwy MA; Peng B; Wu R; Lin J
Hum Reprod; 2016 Apr; 31(4):723-33. PubMed ID: 26874360
[TBL] [Abstract][Full Text] [Related]
12. [Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells].
Gao QQ; Chen H; Chen Y; Xu ZP; Zhu LL; Yu W; Han YF; Dai YT
Zhonghua Nan Ke Xue; 2016 Jun; 22(6):483-490. PubMed ID: 28963834
[TBL] [Abstract][Full Text] [Related]
13. The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells.
Takeba Y; Matsumoto N; Watanabe M; Takenoshita-Nakaya S; Ohta Y; Kumai T; Takagi M; Koizumi S; Asakura T; Otsubo T
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1545-55. PubMed ID: 22481618
[TBL] [Abstract][Full Text] [Related]
14. Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549.
Zhu F; Zhang Z; Wu G; Li Z; Zhang R; Ren J; Nong L
Med Oncol; 2011 Jun; 28(2):565-71. PubMed ID: 20300976
[TBL] [Abstract][Full Text] [Related]
15. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho/Rho kinase pathway.
Li Y; Wu Y; Wang Z; Zhang XH; Wu WK
Med Sci Monit; 2010 Apr; 16(4):BR112-118. PubMed ID: 20357711
[TBL] [Abstract][Full Text] [Related]
16. Targeting ROCK1/2 blocks cell division and induces mitotic catastrophe in hepatocellular carcinoma.
Wu H; Chen Y; Li B; Li C; Guo J; You J; Hu X; Kuang D; Qi S; Liu P; Li L; Xu C
Biochem Pharmacol; 2021 Feb; 184():114353. PubMed ID: 33278350
[TBL] [Abstract][Full Text] [Related]
17. RhoC/ROCK2 promotes vasculogenic mimicry formation primarily through ERK/MMPs in hepatocellular carcinoma.
Zhang JG; Zhang DD; Liu Y; Hu JN; Zhang X; Li L; Mu W; Zhu GH; Li Q; Liu GL
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1113-1125. PubMed ID: 30779947
[TBL] [Abstract][Full Text] [Related]
18. BTBD7 silencing inhibited epithelial- mesenchymal transition (EMT) via regulating Slug expression in human salivary adenoid cystic carcinoma.
Yang L; Wang T; Zhang J; Wang X
Cancer Biomark; 2017 Dec; 20(4):461-468. PubMed ID: 28946551
[TBL] [Abstract][Full Text] [Related]
19. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump.
Lu X; Qin W; Li J; Tan N; Pan D; Zhang H; Xie L; Yao G; Shu H; Yao M; Wan D; Gu J; Yang S
Cancer Res; 2005 Aug; 65(15):6843-9. PubMed ID: 16061667
[TBL] [Abstract][Full Text] [Related]
20. Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion.
Wong CC; Wong CM; Tung EK; Man K; Ng IO
Hepatology; 2009 May; 49(5):1583-94. PubMed ID: 19205033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]